skip to main content
Idioma:
Refinado por: assunto: Female remover Nome da Publicação: British Journal Of Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo

SATO, K ; YUASA, T ; NOGAWA, M ; KIMURA, S ; SEGAWA, H ; YOKOTA, A ; MAEKAWA, T

British journal of cancer, 2006-11, Vol.95 (10), p.1354-1361 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer

Kaira, K ; Sunose, Y ; Arakawa, K ; Ogawa, T ; Sunaga, N ; Shimizu, K ; Tominaga, H ; Oriuchi, N ; Itoh, H ; Nagamori, S ; Kanai, Y ; Segawa, A ; Furuya, M ; Mori, M ; Oyama, T ; Takeyoshi, I

British journal of cancer, 2012-08, Vol.107 (4), p.632-638 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer

KAWAHARA, M ; FURUSE, K ; SEGAWA, Y ; YOSHIMORI, K ; MATSUI, K ; KUDOH, S ; HASEGAWA, K ; NIITANI, H

British journal of cancer, 2001-09, Vol.85 (7), p.939-943 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

TAKIGAWA, N ; KIURA, K ; TABATA, M ; SHINKAI, T ; HIRAKI, S ; TAKEMOTO, M ; KANAZAWA, S ; MATSUO, K ; TANIMOTO, M ; SEGAWA, Y ; WATANABE, Y ; KAMEI, H ; MORITAKA, T ; SHIBAYAMA, T ; UEOKA, H ; GEMBA, K ; YONEI, T

British journal of cancer, 2006-11, Vol.95 (9), p.1142-1144 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Phase I II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer
Phase I II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer

Kiura, K ; Ueoka, H ; Segawa, Y ; Tabata, M ; Kamei, H ; Takigawa, N ; Hiraki, S ; Watanabe, Y ; Bessho, A ; Eguchi, K ; Okimoto, N ; Harita, S ; Takemoto, M ; Hiraki, Y ; Harada, M ; Tanimoto, M

British journal of cancer, 2003-09, Vol.89 (5), p.795-802 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group

SEGAWA, Y ; UEOKA, H ; HARADA, M ; KIURA, K ; KAMEI, H ; TABATA, M ; SAKAE, K ; HIRAKI, Y ; KAWAHARA, S ; EGUCHI, K ; HIRAKI, S

British journal of cancer, 2000-01, Vol.82 (1), p.104-111 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

UEOKA, H ; TABATA, M ; KIURA, K ; SHIBAYAMA, T ; GEMBA, K ; SEGAWA, Y ; CHIKAMORI, K ; YONEI, T ; HIRAKI, S ; HARADA, M

British journal of cancer, 1999-02, Vol.79 (5-6), p.984-990 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.